Pulmonx Corporation
LUNG
$1.38
-$0.01-0.72%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 90.50M | 91.66M | 90.55M | 87.47M | 83.79M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 90.50M | 91.66M | 90.55M | 87.47M | 83.79M |
| Cost of Revenue | 23.36M | 24.48M | 24.39M | 23.21M | 21.79M |
| Gross Profit | 67.14M | 67.19M | 66.16M | 64.27M | 62.00M |
| SG&A Expenses | 101.31M | 105.46M | 105.27M | 103.88M | 102.14M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 144.16M | 148.84M | 147.46M | 145.20M | 141.49M |
| Operating Income | -53.66M | -57.18M | -56.91M | -57.73M | -57.70M |
| Income Before Tax | -53.38M | -56.28M | -56.40M | -56.64M | -55.89M |
| Income Tax Expenses | 626.00K | 478.00K | 542.00K | 449.00K | 500.00K |
| Earnings from Continuing Operations | -54.00 | -56.75 | -56.94 | -57.09 | -56.39 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -54.00M | -56.75M | -56.94M | -57.09M | -56.39M |
| EBIT | -53.66M | -57.18M | -56.91M | -57.73M | -57.70M |
| EBITDA | -52.61M | -56.06M | -55.67M | -56.38M | -56.21M |
| EPS Basic | -1.33 | -1.41 | -1.43 | -1.45 | -1.44 |
| Normalized Basic EPS | -0.82 | -0.87 | -0.89 | -0.90 | -0.89 |
| EPS Diluted | -1.33 | -1.41 | -1.43 | -1.45 | -1.44 |
| Normalized Diluted EPS | -0.82 | -0.87 | -0.89 | -0.90 | -0.89 |
| Average Basic Shares Outstanding | 162.73M | 160.90M | 159.24M | 157.76M | 156.44M |
| Average Diluted Shares Outstanding | 162.73M | 160.90M | 159.24M | 157.76M | 156.44M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |